Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001415889-25-006232 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-27 | BBNX | Mensinger Mike | Chief Product Off | A - Grant | $0.00 | +35.0K | 94.0K | +59% | $0 |
| D | 2025-03-03 | 2025-02-27 | BBNX | Mensinger Mike | Chief Product Off | A - Grant | $0.00 | +52.0K | 52.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | A | A | 35,000 | $0.00 | 94,019 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-02-27 | A | A | 52,000 | $0.00 | 52,000 | D | $19.91 · — to 2035-02-26 | 52,000 Common Stock | (F2) The shares subject to this option shall vest in 36 equal monthly installments measured from February 27, 2025. |